Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Pharmazz

    Client Virtual Booth

    PHARMAZZ

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Pharmazz
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 West 75th Street Suite 105 Willowbrook, IL 60527
    Telephone
    Telephone
    +1 (630)780-6087
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharmazz.com/index.php
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pharmazz-inc-?trk=top_nav_home
    Twitter
    Twitter
    https://twitter.com/Pharmazz

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Dr Reddy's Lab ties up with Pharmazz to market Centhaquine
    Dr Reddy's Lab ties up with Pharmazz to market Centhaquine

    https://timesofindia.indiatimes.com/city/hyderabad/dr-reddys-lab-ties-up-with-pharmazz-to-market-centhaquine/articleshow/108723906.cms

    TIMESOFINDIA
    22 Mar 2024
    Share Share
    Pharmazz & Dr. Reddy's have entered into a lice agreement to market Centhaquine
    Pharmazz & Dr. Reddy's have entered into a lice agreement to market Centhaquine

    https://www.globenewswire.com/news-release/2024/03/22/2850876/0/en/Pharmazz-Inc-and-Dr-Reddy-s-Laboratories-have-entered-into-a-licensing-agreement-to-market-Centhaquine-Lyfaquin-as-a-resuscitative-agent-for-hypovolemic-shock-in-India.html

    GLOBENEWSWIRE
    22 Mar 2024
    Share Share
    A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide
    A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide

    https://www.globenewswire.com//news-release/2023/10/02/2752648/0/en/A-Special-Protocol-Assessment-Agreement-Reached-with-the-U-S-Food-and-Drug-Administration-for-Phase-3-clinical-trial-of-Sovateltide-for-the-treatment-of-acute-cerebral-ischemic-str.html

    GLOBENEWSWIRE
    02 Oct 2023
    Share Share
    Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
    Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

    https://www.indianpharmapost.com/news/sun-pharma-and-pharmazz-ink-agreement-for-introducing-tyvalzi-in-india-14662

    INDIAN PHARMA POST
    15 Sep 2023
    Share Share
    Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India
    Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India

    https://www.globenewswire.com/news-release/2023/05/31/2679520/0/en/Pharmazz-Inc-Announces-Marketing-Approval-of-Sovateltide-in-India-for-Acute-Cerebral-Ischemic-Stroke-Patients.html

    GLOBENEWSWIRE
    31 May 2023
    Share Share
    Pharmazz Announces Publications Regarding the Role of Adrenergic Receptors
    Pharmazz Announces Publications Regarding the Role of Adrenergic Receptors

    https://www.globenewswire.com/news-release/2023/03/20/2630139/0/en/Pharmazz-Inc-Announces-Key-Publications-Regarding-the-Role-of-Adrenergic-Receptors-in-Venous-Blood-Return-to-Treat-Shock.html

    GLOBENEWSWIRE
    20 Mar 2023
    Share Share
    Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide
    Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide

    https://www.prnewswire.com/news-releases/pharmazz-inc-announces-us-fda-clearance-for-a-phase-iii-clinical-trial-of-sovateltide-pmz-1620-in-acute-cerebral-ischemic-stroke-patients-301744465.html

    PR NEWSWIRE
    13 Feb 2023
    Share Share
    EndoStream Announces Patient Enrolled in Trial for Nautilus Intrasaccular System
    EndoStream Announces Patient Enrolled in Trial for Nautilus Intrasaccular System

    https://www.prnewswire.com/news-releases/endostream-medical-announces-first-patient-enrolled-in-us-clinical-trial-for-nautilus-intrasaccular-system-in-treatment-of-cerebral-aneurysms-301744935.html

    PR NEWSWIRE
    13 Feb 2023
    Share Share
    Clinical PIII Trial Results Demonstrating Sovateltide's Efficacy
    Clinical PIII Trial Results Demonstrating Sovateltide's Efficacy

    https://www.prnewswire.com/news-releases/clinical-phase-iii-trial-results-demonstrating-sovateltides-efficacy-to-treat-acute-cerebral-ischemic-stroke-presented-at-the-international-stroke-conference-2023-301741886.html

    PR NEWSWIRE
    10 Feb 2023
    Share Share
    Pharmazz Presents Results of PIII Trial Demonstrating Sovateltide’s Efficacy
    Pharmazz Presents Results of PIII Trial Demonstrating Sovateltide’s Efficacy

    https://www.globenewswire.com/news-release/2022/10/31/2544513/0/en/Pharmazz-Inc-Presents-Positive-Results-of-Phase-III-Clinical-Trial-Demonstrating-Sovateltide-s-Efficacy-as-a-Treatment-for-Acute-Cerebral-Ischemic-Stroke.html

    GLOBENEWSWIRE
    31 Oct 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search